MoonLake Immunotherapeutics-Wall Street Analysts Think MOONLAKE IMMUNO (MLTX) Could Surge 106.62%: Read This Before Placing a Bet

MoonLake Immunotherapeutics (MLTX) closed the last trading session at $36.99, gaining 0.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 76.43 indicates a 106.6% upside potential.The mean estimate comprises 14 short-term price targets with a standard deviation of $13.12. While the lowest estimate of$ 55 indicates a 48.7% increase from the current price level, the most optimistic ...